Home / Resource Library / ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma

ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma

Study examined circulating tumour DNA as a prognostic tool in relapsed lymphomas.